Aone Pharma And Surgicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 28.11%
- Profit Growth -112.04%
- Ebitda 678.85%
- Net Worth -1.30%
- Total Assets -14.70%
About Aone Pharma And Surgicals
Aone Pharma And Surgicals Private Limited (APASPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 July 2013 and has a history of 11 years and six months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Harishchandra Choudhari, Smita Choudhari, and Mangal Choudhari serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397PN2013PTC148146
-
Company No.
148146
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jul 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Aone Pharma And Surgicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harishchandra Choudhari
|
Director | 17-Jul-2013 | Current |
|
Smita Choudhari
|
Director | 30-Aug-2018 | Current |
|
Mangal Choudhari
|
Director | 17-Jul-2013 | Current |
Financial Performance of Aone Pharma And Surgicals.
Aone Pharma And Surgicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.11% increase. The company also saw a substantial fall in profitability, with a 112.04% decrease in profit. The company's net worth dipped by a decrease of 1.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aone Pharma And Surgicals?
In 2021, Aone Pharma And Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Silverline Infrastructure Private LimitedHarishchandra Choudhari and Mangal Choudhari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aone Pharma And Surgicals?
Unlock and access historical data on people associated with Aone Pharma And Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aone Pharma And Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aone Pharma And Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.